Back to Search
Start Over
Acute myeloid leukaemia after treatment with (90)Y-ibritumomab tiuxetan for follicular lymphoma.
- Source :
- Hematological Oncology; Sep2008, Vol. 26 Issue 3, p179-181, 3p
- Publication Year :
- 2008
-
Abstract
- We report here a patient with relapsed follicular lymphoma who developed secondary acute myeloid leukaemia 15 months after radioimmunotherapy (RIT) with (90)Y-ibritumomab tiuxetan, the fifth described case to date. We review the literature for the potential causal relationship between RIT and secondary myelodysplastic syndromes/acute myeloid leukaemia. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 02780232
- Volume :
- 26
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Hematological Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 105567540
- Full Text :
- https://doi.org/10.1002/hon.849